Ca, cAMP & Lipid Signaling
|
| CSTコード | 包装 | 希望納入価格 (円) |
||
|---|---|---|---|---|
| #9921S | 1 Kit | 126,000 | ログインすると国内在庫状況がご確認いただけます。
|
- 2051:
- Immunoprecipitation Western Blotting
- 2052:
- Flow Western Blotting
- 2054:
- Western Blotting
- 9371:
- Western Blotting
- 9374:
- Western Blotting
- 9375:
- Immunoprecipitation Western Blotting
- 9376:
- IHC / Paraffin Western Blotting
- 9377:
- Western Blotting
- 9378:
- Western Blotting
| キット内容 | 容量 | 用途 | 種交差性 | 検出タンパク質の分子量 | Isotype |
|---|---|---|---|---|---|
| Phospho-PKD/PKCmu (Ser916) Antibody #2051 | 40 µl | W IP | H M R Mk | 115 | Rabbit |
| PKD/PKCμ Antibody #2052 | 40 µl | W F | H M R Mk | 115 | Rabbit |
| Phospho-PKD/PKCmu (Ser744/748) Antibody #2054 | 40 µl | W | H M R Mk | 115 | Rabbit |
| Phospho-PKC (pan) (βII Ser660) Antibody #9371 | 40 µl | W | H M R Mk | 78, 80, 82, 85 | Rabbit |
| Phospho-PKCalpha/beta II (Thr638/641) Antibody #9375 | 40 µl | W IP | H M Mk (R) (Hm) | 80, 82 | Rabbit |
| Phospho-PKCdelta (Thr505) Antibody #9374 | 40 µl | W | H M R | 78 | Rabbit |
| Phospho-PKCδ/θ (Ser643/676) Antibody #9376 | 40 µl | W IHC-P | H M R Mk X | 78 | Rabbit |
| Phospho-PKCtheta (Thr538) Antibody #9377 | 40 µl | W | H R Mk B (M) | 79 | Rabbit |
| Phospho-PKCzeta/lambda (Thr410/403) Antibody #9378 | 40 µl | W | H M R Mk | 76 | Rabbit |
| Anti-rabbit IgG, HRP-linked Antibody #7074 | 100 µl | Goat |
| 貯法 | |
|---|---|
| -20℃ |
| ※括弧付きの動物種は配列が100%相同であるため反応すると推定されます。 |
| 社内データ |
|---|
Western Blotting

Western blot analysis of extracts from NIH3T3 cells (lanes 1 & 2) and HeLa cells (lanes 3 & 4), untreated (lanes 1 & 3), PGDF-treated (lane 2), and TNFα-treated (lane 4), using Phospho- PKCζ/λ (Thr410/403) Antibody #9378, and PKCζ Antibody #9368.
Western Blotting

Western blot analysis of extracts from 293 cells, untreated (lane 1), TPA-treated (.2μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho-PKC (pan) (βII Ser660) Antibody #9371, Phospho-PKCα/βII (Thr638/641) Antibody #9375, and PKCα Antibody #2056.
Western Blotting

Western blot analysis of extracts from C6 cells (lanes 1 & 2) and COS cells (lanes 3 & 4), untreated (lanes 1 & 3), or TPA-treated (.2μM for 20 minutes) (lanes 2 & 4), using Phospho-PKD/PKCμ (Ser916) Antibody #2051, Phospho-PKD/PKCμ (Ser744/748) Antibody #2054, PKD/PKCμ Antibody #2052, and β-actin Antibody #4967.
Western Blotting

Western blot analysis of extracts from HeLa cells, untreated (lane 1), TPA-treated (0.2 μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho- PKCδ (Thr505) Antibody #9374, PKCδ Antibody #2058, and β-actin Antibody #4967.
Western Blotting

Western blot analysis of extracts from 293 cells, untreated (lane 1), TPA-treated (.2μM for 20 minutes) (lanes 2 & 3), and CIP/λ phosphatase treated (lane 3), using Phospho-PKCδ/θ (Ser643/676) Antibody #9376, Phospho-PKCθ (Thr538) Antibody #9377, PKCθ Antibody #2059, and β-actin Antibody #4967.
| バックグラウンド |
|---|
Activation of protein kinase C (PKC) is one of the earliest events in a cascade that controls a variety of cellular responses, including secretion, gene expression, proliferation, and muscle contraction (1,2). PKC isoforms belong to three groups based on calcium dependency and activators. Classical PKCs are calcium-dependent via their C2 domains and are activated by phosphatidylserine (PS), diacylglycerol (DAG), and phorbol esters (TPA, PMA) through their cysteine-rich C1 domains. Both novel and atypical PKCs are calcium-independent, but only novel PKCs are activated by PS, DAG, and phorbol esters (3-5). Members of these three PKC groups contain a pseudo-substrate or autoinhibitory domain that binds to substrate-binding sites in the catalytic domain to prevent activation in the absence of cofactors or activators. Control of PKC activity is regulated through three distinct phosphorylation events. Phosphorylation at Thr500 in the activation loop, the autophosphorylation site at Thr641, and at carboxy-terminal hydrophobic site Ser660 occurs in vivo (2). Atypical PKC isoforms lack hydrophobic region phosphorylation, which correlates with the presence of glutamic acid rather than the serine or threonine residues found in more typical PKC isoforms. Either the enzyme PDK1 or a close relative is responsible for PKC activation. A recent addition to the PKC superfamily is PKCμ (PKD), which is regulated by DAG and TPA through its C1 domain. PKD is distinguished by the presence of a PH domain and by its unique substrate recognition and Golgi localization (6). PKC-related kinases (PRK) lack the C1 domain and do not respond to DAG or phorbol esters. Phosphatidylinositol lipids activate PRKs and small Rho-family GTPases bind to the homology region 1 (HR1) to regulate PRK kinase activity (7).
- Nishizuka, Y. (1984) Nature 308, 693-698.
- Keranen, L.M. et al. (1995) Curr. Biol. 5, 1394-1403.
- Mellor, H. and Parker, P.J. (1998) Biochem J. 332 (Pt 2), 281-292.
- Ron, D. and Kazanietz, M.G. (1999) FASEB J. 13, 1658-1676.
- Moscat, J. and Diaz-Meco, M.T. (2000) EMBO Rep. 1, 399-403.
- Baron, C.L. and Malhotra, V. (2002) Science 295, 325-328.
- Flynn, P. et al. (2000) J. Biol. Chem. 275, 11064-11070.
| 使用例 | |
|---|---|
| 製品をご使用いただいて研究を発表されましたら、ぜひお知らせください。 |
本製品は試験研究用です。
